NCT01653613 Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia Status UNKNOWN Phase N/A
NCT01649622 Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) Status WITHDRAWN Phase PHASE2
NCT01643291 Ultrasound Use for Difficult Lumbar Punctures in Pediatric Oncology Patients Status TERMINATED Phase NA
NCT01629745 Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial Status COMPLETED Phase N/A
NCT01626183 Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT01617473 Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant Status WITHDRAWN Phase NA
NCT01615146 Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot Status TERMINATED Phase NA
NCT01608152 Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors Status RECRUITING Phase N/A
NCT01607580 Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD) Status COMPLETED Phase NA
NCT01602952 Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI Status COMPLETED Phase PHASE1/PHASE2
NCT01596257 Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT01596127 Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System Status TERMINATED Phase PHASE1/PHASE2
NCT01593696 Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT01581528 Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A
NCT01575535 S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01572662 Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning Status COMPLETED Phase PHASE2
NCT01570868 Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) Status TERMINATED Phase PHASE2